# reload+after+2024-01-22 14:44:18.117714
address1§822 A1A North
address2§Suite 306
city§Ponte Vedra
state§FL
zip§32082
country§United States
phone§904 300 0701
website§https://www.cadrenal.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
fullTimeEmployees§3
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Quang X. Pham', 'age': 58, 'title': 'Chairman & CEO', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 822173, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Matthew K. Szot CPA, CPA', 'age': 49, 'title': 'Co-Founder & CFO', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 359605, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Douglas W. Losordo FACC, FAHA, M.D.', 'age': 65, 'title': 'Chief Medical Officer', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 23360, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
currency§USD
dateShortInterest§1702598400
forwardEps§-0.45
exchange§NCM
quoteType§EQUITY
shortName§Cadrenal Therapeutics, Inc.
longName§Cadrenal Therapeutics, Inc.
firstTradeDateEpochUtc§1674225000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§ba078ec3-1bff-3797-99d9-a2e1a25e88f8
gmtOffSetMilliseconds§-18000000
targetHighPrice§4.0
targetLowPrice§3.0
targetMeanPrice§3.5
targetMedianPrice§3.5
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§16.164
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
